Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 119, Issue 1, Pages 511-523
Publisher
Wiley
Online
2017-06-13
DOI
10.1002/jcb.26210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vagal nerve activity predicts overall survival in metastatic pancreatic cancer, mediated by inflammation
- (2016) Marijke De Couck et al. Cancer Epidemiology
- Systemic Chemotherapy in Advanced Pancreatic Cancer
- (2016) Hee Seung Lee et al. Gut and Liver
- Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
- (2016) Yuan Wang et al. Drug Design Development and Therapy
- Pancreatic cancer: New hopes after first line treatment
- (2016) Francesca Aroldi et al. World Journal of Gastrointestinal Oncology
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis
- (2014) Gillian K Gresham et al. BMC CANCER
- Brain metastases associated with germ cell tumors may be treated with chemotherapy alone
- (2014) Anna Hardt et al. CANCER
- Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer
- (2014) Takuji Okusaka et al. CANCER SCIENCE
- Progress in the knowledge and treatment of advanced pancreatic cancer: From benchside to bedside
- (2014) Helmut Oettle CANCER TREATMENT REVIEWS
- Chronic Pancreatitis and Pancreatic Cancer
- (2014) Bai-Rong Li et al. GASTROENTEROLOGY
- Improved survival with combined gemcitabine and S-1 for locally advanced pancreatic cancer: pooled analysis of three randomized studies
- (2014) Hiroaki Yanagimoto et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Should Combination Chemotherapy Serve as the Backbone in Clinical Trials of Advanced Pancreatic Cancer?
- (2014) Katherine Van Loon et al. PANCREAS
- A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer
- (2013) Yee Chao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
- (2013) Hunho Song et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer
- (2013) Kentaro Sudo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
- (2013) Hideki Ueno et al. JOURNAL OF CLINICAL ONCOLOGY
- The Quality of Reports of Randomized Controlled Trials Varies between Subdisciplines of Physiotherapy
- (2013) Anne M. Moseley et al. Physiotherapy Canada
- Graphical Tools for Network Meta-Analysis in STATA
- (2013) Anna Chaimani et al. PLoS One
- A Method of Moments Estimator for Random Effect Multivariate Meta-Analysis
- (2012) Han Chen et al. BIOMETRICS
- A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
- (2012) Y Nakai et al. BRITISH JOURNAL OF CANCER
- Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)
- (2012) Masato Ozaka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Systemic treatment of advanced pancreatic cancer
- (2012) Volker Heinemann et al. CANCER TREATMENT REVIEWS
- Drugs in preclinical and early-stage clinical development for pancreatic cancer
- (2012) Swapna Asuthkar et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Quantifying the impact of between-study heterogeneity in multivariate meta-analyses
- (2012) Dan Jackson et al. STATISTICS IN MEDICINE
- Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy
- (2011) Geetanjali Arya et al. Nanomedicine-Nanotechnology Biology and Medicine
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1 clinical trials in 83 patients with pancreatic cancer
- (2010) Christos Vaklavas et al. CANCER
- Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study
- (2010) Giuseppe Colucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing publication bias in meta-analyses in the presence of between-study heterogeneity
- (2010) Jaime L. Peters et al. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now